2013-03-25 - LifeMap Sciences, a Subsidiary of BioTime, Announces Release of LifeMap Discovery™ Version 1.1 with Enhanced Therapeutic Discovery and Commercial Utility

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of LifeMap Discovery™ version 1.1. LifeMap Discovery™ is a key component in LifeMap's integrated database suite, a discovery platform for biomedical and stem cell research, which also includes GeneCards®, the leading human gene database, and MalaCards, the human disease database.